A Study of FZ-AD005 in Patients With Advanced Solid Tumors

Clinical trial NCT06424665 · RECRUITING

Trial details

NCT number: NCT06424665
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma)

Start date: 2024-07-03
Primary completion: 2026-08-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.